-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Send in the Clones: Stem Cell Succession, Replicative Stress and Somatic Reversion

PhD Trainee
Sponsor: Scientific Committee on Stem Cell and Regenerative Medicine
Program: Scientific Program
Saturday, December 5, 2015: 2:00 PM-3:30 PM
Tangerine 1 (WF1), Level 2 (Orange County Convention Center)
Sunday, December 6, 2015: 9:30 AM-11:00 AM
W311, Level 3 (Orange County Convention Center)

Description:

Over the past two years, our understanding of how self-renewal, proliferation and differentiation are balanced within stem cell compartments in vivo has undergone a significant revolution. These recent studies challenge our conventional views connecting self-renewal and multi-lineage potency, and indeed our notions of in vivo clonality per se. As the result, these studies shed new light on key issues as diverse as aging, myelodysplasia and aplasia in hematopoiesis, as well as having broad impact on our understanding of tissue-specific development and homeostasis in general.

Dr. Camargo will first discus recent in vivo studies of hematopoietic clonal persistence in vivo. These studies suggest a new paradigm for understanding basal hematopoiesis and the stress responses created by stem cell transplantation, both experimentally and in the clinic.

Dr. Milsom will then discuss recent findings of how stem cell replication per se engenders metabolic and genomic stress, which links directly to clonal damage, susceptibility to mutation and exhaustion.

Dr. Jongmans will present fascinating evidence that clonal stress and dysfunction can lead not only to hematopoietic deterioration, but also to correction of clonal abnormalities, thus exhibiting positive clonal evolutionary selection within one organismal generation.

Chair:
Stephen G. Emerson, MD, PhD, Columbia University

Disclosures:
No relevant conflicts of interest to declare.

Fernando D. Camargo, PhD

Stem Cell Program, Boston Children's Hospital, Boston, MA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA

Michael D. Milsom, PhD

Experimental Hematology, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany

Marjolijn C. Jongmans, MD, PhD

Radboud University Medical Centre, Nijmegen, Netherlands

See more of: Scientific Program